BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2096327)

  • 1. Modeling of latent inhibition in rats by activation of the central serotoninergic system.
    Loskutova LV; Luk'yanenko FYa ; Il'yuchenok RYu
    Neurosci Behav Physiol; 1990; 20(6):541-2. PubMed ID: 2096327
    [No Abstract]   [Full Text] [Related]  

  • 2. [Simulation of latent inhibition in rats by activation of the central serotoninergic system].
    Loskutova LV; Luk'ianenko FIa; Il'iuchenok RIu
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(6):1157-9. PubMed ID: 2629405
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specifics of participation of dopaminergic and serotoninergic systems of the brain in latent inhibition based on pharmacological models].
    Loskutova LV; Luk'ianenko FIa
    Biull Eksp Biol Med; 1990 Dec; 110(12):616-7. PubMed ID: 2128040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of serotonin- and dopaminergic systems of the brain in mechanisms of latent inhibition in rats.
    Loskutova LV; Luk'yanenko FYa ; Il'yuchenok RYu
    Neurosci Behav Physiol; 1990; 20(6):500-5. PubMed ID: 2096321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The place of the action of the serotoninergic system in the 2-stage process of the formation of latent inhibition in rats].
    Loskutova LV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1998; 48(2):348-51. PubMed ID: 9644816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test.
    Cervo L; Grignaschi G; Rossi C; Samanin R
    Eur J Pharmacol; 1991 Apr; 196(3):217-22. PubMed ID: 1909956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake.
    Koe BK
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():13-7. PubMed ID: 2175308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning takes place in rats with deafferentation of the medial basal hypothalamus.
    Roberts E; Roberts CR; Dubuc PU; Wimer RE; Wimer CC; Jensen RA; Shryne JE; Gorski RA
    Behav Neural Biol; 1982 Oct; 36(2):161-77. PubMed ID: 7183312
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of sertraline: a review.
    Heym J; Koe BK
    J Clin Psychiatry; 1988 Aug; 49 Suppl():40-5. PubMed ID: 3045112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.
    Koe BK; Koch SW; Lebel LA; Minor KW; Page MG
    Eur J Pharmacol; 1987 Sep; 141(2):187-94. PubMed ID: 2824215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of feeding behavior by the serotonin uptake inhibitor sertraline.
    Lucki I; Kreider MS; Simansky KJ
    Psychopharmacology (Berl); 1988; 96(3):289-95. PubMed ID: 3146763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system.
    Sanders-Bush E; Breeding M; Knoth K; Tsutsumi M
    Psychopharmacology (Berl); 1989; 99(1):64-9. PubMed ID: 2550988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic pharmacology of ethanol-serotonin interactions.
    Kalant H
    Clin Neuropharmacol; 1986; 9 Suppl 4():49-51. PubMed ID: 3567955
    [No Abstract]   [Full Text] [Related]  

  • 16. Sertraline potently displaces (+)-[3H]3-PPP binding to sigma sites in rat brain.
    Schmidt A; Lebel L; Koe BK; Seeger T; Heym J
    Eur J Pharmacol; 1989 Jun; 165(2-3):335-6. PubMed ID: 2550252
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin uptake inhibition: in vivo effect of sertraline in rats.
    Manfridi A; Clavenna A; De Simoni MG
    Neurosci Lett; 1992 May; 139(1):69-72. PubMed ID: 1383885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin and alcohol drinking.
    Sellers EM; Higgins GA; Tompkins DM; Romach MK
    NIDA Res Monogr; 1992; 119():141-5. PubMed ID: 1435969
    [No Abstract]   [Full Text] [Related]  

  • 19. Alcohol drinking attenuated by sertraline in rats with 6-OHDA or 5,7-DHT lesions of N. accumbens: a caloric response?
    Myers RD; Quarfordt SD
    Pharmacol Biochem Behav; 1991 Dec; 40(4):923-8. PubMed ID: 1816578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of hippocampal 5-HT in the effects of nicotine on habituation to an X-maze.
    Vale AL; Balfour DJ
    Eur J Pharmacol; 1987 Sep; 141(2):313-7. PubMed ID: 2445590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.